Filing Details

Accession Number:
0001479290-21-000171
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-06 20:34:29
Reporting Period:
2021-12-03
Accepted Time:
2021-12-06 20:34:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479290 Revance Therapeutics Inc. RVNC Pharmaceutical Preparations (2834) 770551645
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818576 Aubrey Rankin C/O Revance Therapeutics, Inc
1222 Demonbreun Street, Suite 2000
Nashville TN 37203
President, Innovation & Tech Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-03 30,000 $14.43 95,463 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 154,302 Indirect The Rankin Irrevocable Trust
Common Stock 321,611 Indirect Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Footnotes
  1. The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.33 to $14.50. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.
  3. These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.